Court Wants To Reassess Damages In NuVasive/Medtronic Patent Fight
This article was originally published in The Gray Sheet
Executive Summary
In a long-standing patent fight between NuVasive and Medtronic, an appeals court has ruled NuVasive was being penalized twice for lost profits based on damages awarded by a jury. The judges unanimously agreed to send the case back to a district court to reevaluate how much Medtronic should be paid.
You may also be interested in...
NuVasive To Settle Medtronic Spinal Patent Suit
The spinal device manufacturer is paying $45m to put the dispute to bed – less than half of a 2011 jury award.
Litigation In Brief
Medtronic v. NuVasive, round one
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.